# SMIM5

## Overview
SMIM5, or small integral membrane protein 5, is a gene that encodes a transmembrane protein involved in various cellular processes. The protein product of SMIM5 is characterized by its integration into cellular membranes, where it participates in protein-protein interactions, notably with other membrane proteins such as PRRT2 and SH3GLB1 (Siddiqui2018Chromosome). SMIM5 has been implicated in cancer biology, particularly in oral squamous cell carcinoma (OSCC) and head and neck squamous cell carcinoma (HNSCC), where it functions as a hub gene within gene modules associated with tumorigenesis and prognosis (Ye2024Identification; Zhang2018Application). Its expression levels have been linked to patient outcomes and drug sensitivity, highlighting its potential as a prognostic biomarker and therapeutic target (Ye2024Identification). Despite its emerging significance, further research is required to fully understand the diverse roles of SMIM5 in cellular physiology and disease.

## Clinical Significance
SMIM5 has been identified as a gene of interest in various cancers, including head and neck squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC). In HNSCC, SMIM5 is associated with a good prognosis and is part of a group of stemness-related genes that have been linked to tumor stemness and immunity. The high expression of SMIM5 in HNSCC is correlated with better patient outcomes, suggesting its potential as a prognostic biomarker (Ye2024Identification). In OSCC, SMIM5 has been validated as a hub gene involved in tumorigenesis. It is part of key gene modules identified through weighted gene co-expression network analysis, indicating its role in the molecular mechanisms underlying OSCC (Zhang2018Application).

The expression of SMIM5 has also been explored in the context of drug sensitivity, with studies indicating that its expression levels may influence the effectiveness of certain chemotherapeutic agents in HNSCC (Ye2024Identification). Despite these findings, the specific clinical significance of SMIM5 mutations or expression alterations in other diseases remains under investigation, and further research is needed to fully elucidate its role in cancer and other conditions.

## Interactions
SMIM5, a small integral membrane protein, has been identified to interact with other membrane proteins through protein-protein interaction (PPI) data. Notably, SMIM5 interacts with PRRT2 and SH3GLB1, which are also membrane proteins. These interactions were identified using yeast two-hybrid (Y2H) assays, a method particularly useful for studying membrane proteins that are challenging to solubilize for mass spectrometry analysis (Siddiqui2018Chromosome).

In the context of oral squamous cell carcinoma (OSCC), SMIM5 was identified as a hub gene within a module negatively correlated with tumorigenesis. This module is enriched in processes related to epidermis development and differentiation, suggesting that SMIM5 may play a role in these biological pathways (Zhang2018Application). Although specific physical interactions of SMIM5 in OSCC are not detailed, its inclusion as a hub gene indicates its potential involvement in significant protein networks related to cancer biology (Zhang2018Application).

Overall, while detailed interaction partners of SMIM5 are limited, its identification through PPI data and its role in cancer-related gene modules suggest it participates in important cellular interactions.


## References


[1. (Ye2024Identification) Zhihua Ye, Mintao Xiao, Yinping Zhang, Anfu Zheng, Duoli Zhang, Jie Chen, Fukuan Du, Yueshui Zhao, Xu Wu, Mingxing Li, Yu Chen, Shuai Deng, Jing Shen, Xinyi Zhang, Qinglian Wen, Junkai Zhang, and Zhangang Xiao. Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma. Scientific Reports, July 2024. URL: http://dx.doi.org/10.1038/s41598-024-66196-6, doi:10.1038/s41598-024-66196-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-66196-6)

[2. (Zhang2018Application) Xiaoqi Zhang, Hao Feng, Ziyu Li, Dongfang Li, Shanshan Liu, Haiyun Huang, and Minqi Li. Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis. OncoTargets and Therapy, Volume 11:6001–6021, September 2018. URL: http://dx.doi.org/10.2147/OTT.S171791, doi:10.2147/ott.s171791. This article has 115 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S171791)

[3. (Siddiqui2018Chromosome) Omer Siddiqui, Hongjiu Zhang, Yuanfang Guan, and Gilbert S. Omenn. Chromosome 17 missing proteins: recent progress and future directions as part of the next-mp50 challenge. Journal of Proteome Research, 17(12):4061–4071, October 2018. URL: http://dx.doi.org/10.1021/acs.jproteome.8b00442, doi:10.1021/acs.jproteome.8b00442. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.8b00442)